Lance A. Smith

2.3k total citations
38 papers, 1.9k citations indexed

About

Lance A. Smith is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Lance A. Smith has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 20 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Lance A. Smith's work include Neuroscience and Neuropharmacology Research (28 papers), Parkinson's Disease Mechanisms and Treatments (19 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Lance A. Smith is often cited by papers focused on Neuroscience and Neuropharmacology Research (28 papers), Parkinson's Disease Mechanisms and Treatments (19 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Lance A. Smith collaborates with scholars based in United Kingdom, United States and Finland. Lance A. Smith's co-authors include Peter Jenner, Michael S. Jackson, R. K. B. Pearce, Michael Jackson, Peter Jenner, Yoshihisa Kuwana, Joji Nakamura, Hiroshi Kase, Sarah Rose and C. D. Marsden and has published in prestigious journals such as Journal of Neuroscience, Annals of Neurology and Brain Research.

In The Last Decade

Lance A. Smith

38 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lance A. Smith United Kingdom 26 1.2k 1.1k 387 381 287 38 1.9k
Francesco Bibbiani United States 17 1.0k 0.8× 1.1k 0.9× 313 0.8× 308 0.8× 138 0.5× 34 1.9k
Akihisa Mori Japan 27 1.3k 1.1× 1.0k 0.9× 1.4k 3.6× 727 1.9× 155 0.5× 59 2.5k
Elisabetta Tronci Italy 20 658 0.5× 728 0.6× 130 0.3× 199 0.5× 112 0.4× 32 1.0k
Hermann Russ Germany 23 699 0.6× 807 0.7× 47 0.1× 360 0.9× 166 0.6× 46 1.5k
Chang‐Lin Liang United States 19 561 0.5× 745 0.7× 63 0.2× 403 1.1× 86 0.3× 24 1.4k
Jolanta Konieczny Poland 20 449 0.4× 655 0.6× 114 0.3× 346 0.9× 50 0.2× 47 975
José Luís Albasanz Spain 22 169 0.1× 645 0.6× 624 1.6× 666 1.7× 99 0.3× 71 1.6k
Joanne E. Nash Canada 22 513 0.4× 1.2k 1.1× 70 0.2× 790 2.1× 204 0.7× 33 1.9k
Mairena Martı́n Spain 23 176 0.1× 705 0.6× 687 1.8× 749 2.0× 86 0.3× 91 1.8k
Javier Burgueño Spain 22 181 0.1× 1.4k 1.3× 821 2.1× 1.6k 4.2× 137 0.5× 43 2.5k

Countries citing papers authored by Lance A. Smith

Since Specialization
Citations

This map shows the geographic impact of Lance A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance A. Smith more than expected).

Fields of papers citing papers by Lance A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance A. Smith. The network helps show where Lance A. Smith may publish in the future.

Co-authorship network of co-authors of Lance A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Lance A. Smith. A scholar is included among the top collaborators of Lance A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance A. Smith. Lance A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hurley, Michael J., Michael S. Jackson, Lance A. Smith, Sarah Rose, & Peter Jenner. (2013). Proteomic Analysis of Striatum from MPTP-Treated Marmosets (Callithrix jacchus) with l-DOPA-Induced Dyskinesia of Differing Severity. Journal of Molecular Neuroscience. 52(2). 302–312. 4 indexed citations
2.
Jackson, Michael S., et al.. (2011). A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. Behavioural Pharmacology. 22(3). 269–274. 9 indexed citations
3.
Rose, Sarah, et al.. (2007). Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates. Behavioural Pharmacology. 18(2). 155–160. 17 indexed citations
4.
Jackson, Michael S., Lance A. Smith, Ghassan Al‐Barghouthy, Sarah Rose, & Peter Jenner. (2006). Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets. Experimental Neurology. 204(1). 162–170. 38 indexed citations
5.
Jackson, Michael S., et al.. (2006). Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease. Brain Research. 1118(1). 239–250. 46 indexed citations
6.
Iravani, Mahmoud M., Emilie Syed, Michael S. Jackson, et al.. (2005). A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. European Journal of Neuroscience. 21(4). 841–854. 57 indexed citations
7.
8.
Millan, Mark J., Benjamin Di Cara, Michael P. Hill, et al.. (2004). S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: II. Actions in Rodent, Primate, and Cellular Models of Antiparkinsonian Activity in Comparison to Ropinirole. Journal of Pharmacology and Experimental Therapeutics. 309(3). 921–935. 42 indexed citations
9.
10.
Smith, Lance A., et al.. (2002). Dopamine, but Not Norepinephrine or Serotonin, Reuptake Inhibition Reverses Motor Deficits in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Primates. Journal of Pharmacology and Experimental Therapeutics. 303(3). 952–958. 58 indexed citations
11.
Kuoppamäki, Mikko, Ghassan Al‐Barghouthy, Michael S. Jackson, et al.. (2002). Beginning‐of‐dose and rebound worsening in MPTP‐treated common marmosets treated with levodopa. Movement Disorders. 17(6). 1312–1317. 21 indexed citations
12.
Smith, Lance A., et al.. (2000). Transdermal Administration of Piribedil Reverses MPTP-induced Motor Deficits in the Common Marmoset. Clinical Neuropharmacology. 23(3). 133–142. 28 indexed citations
13.
Kanda, Tomoyuki, Michael S. Jackson, Lance A. Smith, et al.. (2000). Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys. Experimental Neurology. 162(2). 321–327. 202 indexed citations
14.
Kanda, Tomoyuki, Michael Jackson, Lance A. Smith, et al.. (1998). Adenosine A2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys. Annals of Neurology. 43(4). 507–513. 279 indexed citations
15.
Smith, Lance A., Ariel Gordin, Peter Jenner, & C. D. Marsden. (1997). Entacapone enhances levodopa‐induced reversal of motor disability in MPTP‐treated common marmosets. Movement Disorders. 12(6). 935–945. 40 indexed citations
16.
17.
Urwyler, Stephan, Elizabeth Campbell, Gert Fricker, et al.. (1996). Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-Methyl-D-aspartate receptor antagonists—II. Pharmacological characterization in vivo. Neuropharmacology. 35(6). 655–669. 27 indexed citations
18.
Gnanalingham, Kanna, et al.. (1995). Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset. Psychopharmacology. 117(3). 275–286. 51 indexed citations
19.
Gnanalingham, Kanna, Lance A. Smith, A. Jackie Hunter, Peter Jenner, & C. D. Marsden. (1993). Alterations in striatal and extrastriatal D‐1 and D‐2 dopamine receptors in the MPTP‐treated common marmoset: An autoradiographic study. Synapse. 14(2). 184–194. 63 indexed citations
20.
Marshall, Guillermo, et al.. (1986). Métodos de seguimiento de la interfase para problemas unidimensionales de frontera móvil II. Revista Internacional de Métodos Numéricos para Cálculo y Diseño en Ingeniería. 2(4). 351–366. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Bibbiani Breakdown of academic impact, for papers by Akihisa Mori Breakdown of academic impact, for papers by Elisabetta Tronci Breakdown of academic impact, for papers by Hermann Russ Breakdown of academic impact, for papers by Chang‐Lin Liang Breakdown of academic impact, for papers by Jolanta Konieczny Breakdown of academic impact, for papers by José Luís Albasanz Breakdown of academic impact, for papers by Joanne E. Nash Breakdown of academic impact, for papers by Mairena Martı́n Breakdown of academic impact, for papers by Javier Burgueño
Rankless by CCL
2026